Atrys Health (CHIX:ATRYE) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:ATRYE Atrys Health SA CHIX:ATRYE
65 GF Score
Price €6.08
GF Value €7.71
! 5 Warning Signs
View Full Analysis

What is Atrys Health FFO per Share?

FFO per Share only applies to REITs.

CHIX:ATRYE
65GF Score
Atrys Health SA CHIX:ATRYE
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Atrys Health (CHIX:ATRYE) Overvalued in 2026?

Based on GuruFocus' analysis, Atrys Health stock appears to be undervalued. The current stock price of €6.08 is trading 21.1% below its estimated GF Value™ of €7.71.

Key valuation signals for CHIX:ATRYE:

  • FFO per Share:
  • GF Value™: €7.71 vs. price of €6.08 (21.1% below fair value)
  • GF Score™: 65/100 with 5 warning signs

No single metric tells the full story. See the CHIX:ATRYE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Atrys Health Business Description

Other Exchanges ATRY:SpainA2T:Germany
Address Calle Provenca, 392 planta baja, Barcelona, ESP, 08025
Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.
65GF Score

Get the complete analysis for CHIX:ATRYE

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.08
Price
€7.71
GF Value